Stockreport

Acadia Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Operating Overview

ACADIA Pharmaceuticals Inc.  (ACAD) 
Last acadia pharmaceuticals inc. earnings: 2/26 04:05 pm Check Earnings Report
PDF - 2024 total net product sales of $957.8 million, reflecting 32% revenue growth- Fourth quarter DAYBUE® (trofinetide) net product sales of $96.7 million and full year 20 [Read more]